Kaplan and Sadocks Comprehensive Textbook of Psychiatry, 11e

x

Contents

10 NEUROCOGNITIVE DISORDERS

7.2 The Psychiatric Report and Outline for a Psychiatric Examination Benjamin J. Sadock, M.D. 7.3 Practice Guidelines in Psychiatry Laura J. Fochtmann, M.D., M.B.I., and John S. McIntyre, M.D. 7.4 Neuropsychological Assessment of Adults

1228 1228

1007

10.1 Cognitive Disorders: Introduction

Iqbal Ahmed, M.D., F.R.C.Psych.

1012

10.2 Delirium

1229 Mandayam Sujata, M.D., Marie Anne Gebara, M.D., Tanya Fabian, Pharm.D., Ph.D., and LalithKumar Solai, M.D. 1238 Julie Graziane, M.D., and Iqbal Ahmed, M.D., F.R.C.Psych.

1018 Joseph R. Sadek, Ph.D., A.B.P.P.-C.N., Owen Gaasedelen, Ph.D., Rex M. Swanda, Ph.D., A.B.P.P.-C.N., and Kathleen Y. Haaland, Ph.D., A.B.P.P.-C.N. 1035 Russell L. Adams, Ph.D., A.B.P.P-NP., C.L., and David L. Adams, Psy.D., B.C.B.A.-D.

10.3 Major Neurocognitive Disorders (Dementia)

10.4 Mild Cognitive Impairment and Amnestic Disorders Daniel Varon, M.D., and Carmen Andreescu, M.D. 10.5 Cognitive Disorders Due to Another Medical Condition or Substance

7.5 Personality Assessment of Adults

1273

7.6 Medical Assessment and Laboratory Testing in Psychiatry Jennifer L. Kruse, M.D., and John O. Brooks, III, Ph.D., M.D. 7.7 Principles and Applications of

1049

1284

Robert J. Boland, M.D., and Iqbal Ahmed, M.D., F.R.C.Psych. 11 SUBSTANCE-RELATED DISORDERS 1293 11.1 Substance Use Disorders: Introduction 1293 Joji Suzuki, M.D. 11.2 Alcohol-Related Disorders 1296 Marc A. Schuckit, M.D. 11.3 Stimulant-Related Disorders 1312 Rocco A. Iannucci, M.D., and Roger D. Weiss, M.D. 11.4 Caffeine-Related Disorders 1324

Quantitative Electroencephalography in Psychiatry

1068

Leslie S. Prichep, Ph.D. 7.8 Psychiatric Rating Scales

1090 Samuel Justin Sinclair, Ph.D., Mark A. Blais, Psy.D., and Deborah Blacker, M.D., Sc.D.

7.9 Electronic Media in Psychiatry Zebulon Taintor, M.D. 7.10 Cultural Competency in the Organization and Delivery of Psychiatric Care

1121

1136 Carole E. Siegel, Ph.D., Helena B. Hansen, M.D., Ph.D., and Jonathan Michel Metzl, M.D., Ph.D.

Laura M. Juliano, Ph.D., and Mary Margaret Sweeney, Ph.D. 11.5 Cannabis-Related Disorders

1337 Janni Leung, Ph.D., Wayne D. Hall, Ph.D., and Louisa Degenhardt, Ph.D. 1347 Brian S. Barnett, M.D., and Joji Suzuki, M.D. 1365 Cameron J. Davidson, Ph.D., D.W. Svenson, M.A., and Scott E. Bowen, Ph.D.

7.11 Medical Error

1150

Nora C. Oberfield, M.D.

11.6 Hallucinogen-Related Disorders

8 CLINICAL MANIFESTATIONS OF PSYCHIATRIC DISORDERS 1161 Anu A. Matorin, M.D., Andres A. Avellaneda Ojeda, M.D., Asim A. Shah, M.D., and Pedro Ruiz, M.D. 9 CLASSIFICATION IN PSYCHIATRY 1198 9.1 Present and Future of Classification Systems for Mental Disorders 1198 Javier I. Escobar, M.D., M.Sc., and Humberto Marin, M.D. 9.2 The Classification of Mental Disorders in the International Classification of Diseases (ICD-11) 1213

11.7 Inhalant-Related Disorders

11.8 Tobacco-Related Disorders

1382

Smita Das, M.D., Ph.D., M.P.H., Brian Isakson, Ph.D., and Douglas M. Ziedonis, M.D., M.P.H. 11.9 Opioid Use and Related Disorders: From Neuroscience to Treatment

1395

Sean X. Luo, M.D., Ph.D., and Adam Bisaga, M.D.

11.10 Sedative-, Hypnotic-, or

Copyright © 2025 Wolters Kluwer, Inc. Unauthorized reproduction of this content is prohibited. Javier I. Escobar, M.D., M.Sc., and Carlos López-Jaramillo, M.D., Ph.D. Anxiolytic-Related Disorders 1419

John J. Mariani, M.D.